PATENT CLAIM ANALYSIS

Application Number: 16358021
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-07
Patent Classification: ["514", "356000"]

Abstract:
Disclosed herein are methods of treating disease with a combination of a RXR agonist and a thyroid hormone.

Claim (Index 13):
The method according to  claim 1 , wherein treatment with the combination of RXR agonist and thyroid hormone reduces at least one symptom of traumatic CNS injury, wherein the at least one symptom reduced is inflammation, fatigue, dizziness, headache, malaise, elevated fever and high body temperature, extreme sensitivity to cold in the hands and feet, weakness and stiffness in muscles and joints, weight changes, digestive or gastrointestinal problems, low or high blood pressure, irritability, anxiety, or depression, blurred or double vision, ataxia, clonus, dysarthria, fatigue, clumsiness, hand paralysis, hemiparesis, genital anesthesia, incoordination, paresthesias, ocular paralysis, impaired muscle coordination, weakness (muscle), loss of sensation, impaired vision, neurological symptoms, unsteady gait, spastic paraparesis, incontinence, hearing problems, or speech problems.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 99.0
- Lexical Diversity: 1.1875
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16296012', '16118001', '15339762', '15339752', '15812821']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.9031784920433786
- 35 USC 102 Novelty (BERT): 0.6650258936519216
- Combined Prediction Score: 0.879363232204233
- Mean Citation Score: 747.8447739999997
- Max Citation Score: 778.67737
- Similarity Product: 588.0892896029367

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test